n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Creutzfeldt-Jakob Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clark, DB; Coupal, JJ; DeKosky, ST; DeLand, FH; Domstad, PA; Goldstein, S; Kung, H; Markesbery, WR; Shih, WJ | 1 |
1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Creutzfeldt-Jakob Syndrome
Article | Year |
---|---|
Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease).
Topics: Aged; Brain; Creutzfeldt-Jakob Syndrome; Humans; Iodobenzenes; Male; Radionuclide Imaging | 1987 |